US FDA withdraws emergency use of HCQ for treating coronavirus COVID-19 patients

The US Food and Drug Administration (FDA) on Monday (June 15)  withdrew the emergency use authorisation of anti-malarial drug hydroxychloroquine in the treatment of COVID-19 patients saying that the drug, which was called as 'game-changer' in treatment of COVID-19, may not be effective to cure the deadly virus infection.

from Zee News :World https://ift.tt/30LjJdZ

• Tweet
• Share
• Share
• Share
• Share